Part II: Biologic Augmentation Strategies as Useful Adjuncts in Musculoskeletal Surgery.

J Arthroplasty · Aug 2025 · Review

Rainey JP, Goodman SB, Jones LC, Sequeira SB, Mont MA

LifeBridge Health, Sinai Hospital of Baltimore, Rubin Institute for Advanced Orthopedics, Maryland

General Orthopaedics Orthopaedic Trauma

SUMMARY — THE REDUCTIONReview of biologic augmentation such as bone marrow aspirate concentrate and mesenchymal stem cells for arthritis, osteonecrosis, and nonunion; results look positive, but larger long-term randomized trials are still needed.
Abstract, as published

Osseous healing after injury, whether by arthritis, osteonecrosis, or fracture, follows a fairly predictable and stepwise order of events. New bone formation requires osteoinductive, osteoconductive, and osteogenetic signals and environments for rapid and complete healing. Biologic augmentation strategies, such as bone marrow aspirate concentrates and other forms of mesenchymal stem cells, have been studied with renewed interest as a way to enhance healing in patients who have osteoarthritis, osteonecrosis, delayed unions, and nonunions. Many studies have demonstrated positive results in favor of biologic augmentation strategies to treat or temporize arthritis, osteonecrosis, and nonunion. Future research is required to definitively determine the utility of these biologic augmentation strategies, and larger randomized controlled trials with longer-term follow ups are needed.

Featured in the 2026-10-19 issue.

← Medicare in the 21 st Century: Understanding the Program to P…

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.